Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now shows Revision: v3.3.2 as the latest version, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedRecord History now shows a new Revision: v3.3.1 and the removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the banner note about a lapse in government funding and related operating status from the page.SummaryDifference0.7%

- Check43 days agoChange DetectedNew entries appear in the Record History with updates to Study Status and Eligibility across multiple versions, reflecting changes to recruitment and oversight details of the study.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference12%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.